During the past decade, The Second Affiliated Hospital of Hainan Medical University conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Second Affiliated Hospital of Hainan Medical University" #1 sponsor was "Timmune Biotech Inc." with 3 trials, followed by "Ark Biosciences Inc." with 1 trials sponsored, "Chen Xiangmei" with 1 trials sponsored, "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 1 trials sponsored and "Chinese PLA General Hospital" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Second Affiliated Hospital of Hainan Medical University" #1 collaborator was "Jiangsu Suzhong Pharmaceutical Group Co., Ltd." with 2 trials as a collaborator, "Hainan Cancer Hospital" with 1 trials as a collaborator and "The Second Affiliated Hospital of Hainan Medical University" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "The Second Affiliated Hospital of Hainan Medical University" are "Chronic Kidney Disease" (1 trials), "Coronary Heart Disease" (1 trials), "Esophagus Cancer" (1 trials), "Extensive Small Cell Lung Cancer" (1 trials) and "G6PD Deficiency" (1 trials). Many other conditions were trialed in "The Second Affiliated Hospital of Hainan Medical University" in a lesser frequency.

Most popular intervention types in "The Second Affiliated Hospital of Hainan Medical University" are "Drug" (7 trials), "Biological" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "AK0529" (1 trials), "Abelmoschus manihot" (1 trials), "Abelmoschus manihot (AM)" (1 trials) and "Anlotinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Second Affiliated Hospital of Hainan Medical University" are 12 trials for "All" genders.

Currently, there are NaN active trials in "The Second Affiliated Hospital of Hainan Medical University". 1 are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in The Second Affiliated Hospital of Hainan Medical University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Second Affiliated Hospital of Hainan Medical University, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".